Qing Zhai

1.2k total citations
60 papers, 869 citations indexed

About

Qing Zhai is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Qing Zhai has authored 60 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Qing Zhai's work include Neuropeptides and Animal Physiology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Qing Zhai is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Qing Zhai collaborates with scholars based in China, Japan and United States. Qing Zhai's co-authors include Qiong Du, Bin Zhu, Xuan Ye, Richard J. Traub, Fred Nyberg, Bo Yu, Bo Yu, P. Roos, Hongyue Liu and Huan Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Pain and International Journal of Molecular Sciences.

In The Last Decade

Qing Zhai

54 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Zhai China 18 377 218 117 117 101 60 869
Xiaojie Zhang China 21 367 1.0× 101 0.5× 97 0.8× 143 1.2× 85 0.8× 61 1.0k
Junjian Huang United States 13 468 1.2× 92 0.4× 86 0.7× 152 1.3× 147 1.5× 59 967
Yu‐Ting Xuan United States 11 581 1.5× 104 0.5× 147 1.3× 160 1.4× 64 0.6× 15 1.2k
Xiaoou Sun China 18 505 1.3× 233 1.1× 116 1.0× 151 1.3× 75 0.7× 35 994
Parkyong Song South Korea 17 612 1.6× 112 0.5× 118 1.0× 220 1.9× 55 0.5× 38 1.2k
Cunjin Su China 16 396 1.1× 156 0.7× 69 0.6× 155 1.3× 95 0.9× 30 823
Qiuhuan Yuan China 20 470 1.2× 136 0.6× 68 0.6× 141 1.2× 44 0.4× 44 1.1k
Mitsuhisa Koga Japan 18 379 1.0× 81 0.4× 145 1.2× 125 1.1× 41 0.4× 44 1.1k
Wei Yin United States 15 740 2.0× 105 0.5× 89 0.8× 176 1.5× 226 2.2× 34 1.5k

Countries citing papers authored by Qing Zhai

Since Specialization
Citations

This map shows the geographic impact of Qing Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Zhai more than expected).

Fields of papers citing papers by Qing Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Zhai. The network helps show where Qing Zhai may publish in the future.

Co-authorship network of co-authors of Qing Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Zhai. A scholar is included among the top collaborators of Qing Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Zhai. Qing Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shiqiang, Yong Sun, Lijun Xu, et al.. (2025). Integrated Multi-omics and Experimental Validation Reveal FDX1/LIAS-Mediated Cuproptosis as a Potential Driver of Diabetic Kidney Disease. Biological Trace Element Research. 204(3). 1969–1982.
2.
Wang, Mengmeng, et al.. (2024). Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study. Pharmaceuticals. 17(8). 1025–1025. 5 indexed citations
3.
Chen, Bin, Md. Shoriful Islam, Qing Zhai, et al.. (2024). UBL3 Interacts with PolyQ-Expanded Huntingtin Fragments and Modifies Their Intracellular Sorting. Neurology International. 16(6). 1175–1188. 2 indexed citations
4.
5.
Chen, Bin, Qing Zhai, Chi Zhang, et al.. (2023). UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib. Biomedicines. 11(6). 1685–1685. 7 indexed citations
6.
Chen, Bin, Chi Zhang, Qing Zhai, et al.. (2023). A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins—UBL3. International Journal of Molecular Sciences. 24(2). 1231–1231. 4 indexed citations
7.
Chen, Bin, et al.. (2022). Traumatic optic neuropathy: a review of current studies. Neurosurgical Review. 45(3). 1895–1913. 43 indexed citations
8.
Du, Qiong, Xuan Ye, Huan Li, et al.. (2021). Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA3. Journal of Gastrointestinal Oncology. 12(1). 52–68. 39 indexed citations
9.
Liu, Hongyue, Qiong Du, Hui Zhang, et al.. (2021). Efficacy and safety of domestic and imported gefitinib in patients with advanced non-small cell lung cancer. Annals of Palliative Medicine. 10(1). 10–15. 5 indexed citations
10.
Ye, Xuan, Xin Luo, Qiong Du, et al.. (2020). Efficacy and safety of lapatinib in Chinese breast cancer patients: a real-world study. Annals of Translational Medicine. 8(5). 240–240. 3 indexed citations
11.
Li, Huan, Qing Zhai, & Bo Yu. (2018). The clinical benefit of epidermal growth factor receptor and human epidermal growth factor receptor 2 targeted agents adding to endocrine therapy in hormone receptor-positive breast cancer. Journal of Cancer Research and Therapeutics. 14(Suppl 1). S218–S223. 2 indexed citations
12.
Zhai, Qing, Yun Wang, & Ayong Tian. (2017). Severe hemodynamic instability after indocyanine green injection during off-pump coronary artery bypass grafting. Medicine. 96(46). e8766–e8766. 8 indexed citations
13.
Zhai, Qing, et al.. (2017). Neutropenic complications in Chinese patients with breast cancer in a real-world setting. International Journal of Clinical and Experimental Pathology. 10(1). 651–660. 4 indexed citations
14.
Ye, Xuan, Qiong Du, Huan Li, Bo Yu, & Qing Zhai. (2016). Calcium Channel Blockers and Risk of Breast Cancer: A meta-Analysis. 9(10). 20425–20431. 2 indexed citations
15.
Du, Qiong, et al.. (2013). Role of mitochondrial permeability transition in human hepatocellular carcinoma Hep-G2 cell death induced by rhein. Fitoterapia. 91. 68–73. 44 indexed citations
16.
Zhai, Qing, et al.. (2010). Protective activity of Jiang-Zhi-Li-Gan against carbon tetrachloride-induced hepatic injury in mice. Pharmaceutical Biology. 48(2). 231–233.
17.
18.
Yu, Bo, et al.. (2007). The cytotoxicity of lingshuiol: A comparative study with amphidinol 2 on membrane permeabilizing activities. Toxicon. 50(2). 278–282. 6 indexed citations
19.
Traub, Richard J., Qing Zhai, Yuxi Ji, & Marina Kovalenko. (2002). NMDA receptor antagonists attenuate noxious and nonnoxious colorectal distention-induced Fos expression in the spinal cord and the visceromotor reflex. Neuroscience. 113(1). 205–211. 38 indexed citations
20.
Zhai, Qing, et al.. (1994). Characterization of growth hormone binding sites in rat brain. Acta Paediatrica. 83(s406). 92–95. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojie Zhang Breakdown of academic impact, for papers by Junjian Huang Breakdown of academic impact, for papers by Yu‐Ting Xuan Breakdown of academic impact, for papers by Xiaoou Sun Breakdown of academic impact, for papers by Parkyong Song Breakdown of academic impact, for papers by Cunjin Su Breakdown of academic impact, for papers by Qiuhuan Yuan Breakdown of academic impact, for papers by Mitsuhisa Koga Breakdown of academic impact, for papers by Wei Yin
Rankless by CCL
2026